How much funding has Restore Vision Inc raised?

Restore Vision Inc has raised $2.8M in total funding, most recently a Series A round.

Who are Restore Vision Inc's investors?

Restore Vision Inc's investors include Shionogi, Remiges Ventures, Kyoto University Innovation Capital, ANRI, Real Tech Holdings.

When was Restore Vision Inc founded?

Restore Vision Inc was founded in 2019.

Where is Restore Vision Inc headquartered?

Restore Vision Inc is headquartered in Kobe, United States.

What industry is Restore Vision Inc in?

Restore Vision Inc operates in Healthcare, Biotech.

How many employees does Restore Vision Inc have?

Restore Vision Inc has 1-10 employees.

Restore Vision Inc

Light at the End of the Tunnel

Kobe, United States · Founded 2019 · $2.8M raised

Healthcare

Biotech

Headquarters: Kobe
Employees: 1–10
Founded: 2019
Business Model: B2B

Website: restore-vis.com
Total Funding: $2.8M
Last Round: $2.8M Series AApr 2026
Rounds: 3

About

Restore Vision Inc. is a clinical-stage gene therapy company developing transformative treatments for inherited retinal diseases (IRDs) such as retinitis pigmentosa. Its lead program RV-001 uses a gene-agnostic approach — Chimeric opsin technology — to restore light sensitivity regardless of the underlying genetic mutation. The company is currently conducting Phase I/II clinical trials.

Summary

Restore Vision Inc is a Healthcare company based in Kobe, United States, founded in 2019. It has raised $2.8M in total across 3 rounds, most recently a $2.8M Series A round in Apr 2026. Investors include Shionogi, Remiges Ventures and Kyoto University Innovation Capital.